Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine IV Injection for Neuropathic Pain After Mastectomy
NCT07475520Completed
- Sponsor
- Cairo University
- Start
- Jul 2022
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of Lidocaine Hydrochloride Injection, without epinephrine in neuropathic pain (2 arms), sponsored by Cairo University. Primary endpoint: Neuropathic Pain Scale at 1 week. Started Jul 2022; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT07475520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475520.